![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Stroupe K.T.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.17, Iss.5, 2000-05, pp. : 429-440
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inpatient costs lower with torasemide than furosemide
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Torasemide outshines furosemide in QOL stakes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Torasemide: A Pharmacoeconomic Review of its Use in Chronic Heart Failure
PharmacoEconomics, Vol. 19, Iss. 6, 2001-06 ,pp. :